Clinical Trials
7 trialsNCT05919264 2026-05-28
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Parabilis Medicines, Inc.
Phase 1/2 Recruiting
NCT05007106 2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT02069041 2018-11-21
A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01489566 2011-12-14
Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT00559455 2011-06-28
Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma
Sanofi
Phase 2 Completed
NCT00471965 2010-09-20
EACH
Sanofi
Phase 3 Completed
NCT00644020 2008-03-26
Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Unknown